Accessibility Menu
 
Rua Life Sciences Plc logo

Rua Life Sciences Plc

(LSE) RUA

Current Price$0.20
Market Cap$1.21B
Since IPO (1997)-98%
5 Year-86%
1 Year+68%
1 Month+53%

Rua Life Sciences Plc Financials at a Glance

Market Cap

$1.21B

Revenue (TTM)

$8.57M

Net Income (TTM)

$144.33K

EPS (TTM)

$-0.23

P/E Ratio

-84.78

Dividend

$0.00

Beta (Volatility)

-0.03 (Low)

Price

$0.20

Volume

475,132

Open

$20.00

Previous Close

$19.80

Daily Range

$19.00 - $20.01

52-Week Range

$10.42 - $20.94

RUA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rua Life Sciences Plc

Industry

Healthcare Equipment and Supplies

CEO

Bill Brown

Headquarters

Irvine, KA11 5AN, GB

RUA Financials

Key Financial Metrics (TTM)

Gross Margin

69%

Operating Margin

-19%

Net Income Margin

-3%

Return on Equity

0%

Return on Capital

-10%

Return on Assets

-2%

Earnings Yield

-1.18%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.21B

Shares Outstanding

62.06M

Volume

475.13K

Avg. Volume

202.08K

Financials (TTM)

Gross Profit

$3.06M

Operating Income

$826.67K

EBITDA

$383.33K

Operating Cash Flow

$137.00K

Capital Expenditure

$161.00K

Free Cash Flow

$298.00K

Cash & ST Invst.

$3.25M

Total Debt

$794.00K

Rua Life Sciences Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$2.59M

+85.3%

Gross Profit

$1.66M

+50.9%

Gross Margin

64.12%

N/A

Market Cap

$1.21B

N/A

Market Cap/Employee

$30.25M

N/A

Employees

40

N/A

Net Income

$630.00K

-46.5%

EBITDA

$1.10M

-175.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.46M

-30.7%

Accounts Receivable

$1.25M

+135.0%

Inventory

$894.00K

+698.2%

Long Term Debt

$560.00K

+105.9%

Short Term Debt

$234.00K

+100.0%

Return on Assets

-1.59%

N/A

Return on Invested Capital

-10.39%

N/A

Free Cash Flow

$2.00K

+100.4%

Operating Cash Flow

$29.00K

+106.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GDR.LGenedrive Plc
$0.95+2.70%
CNSL.LCambridge Nutritional Sciences plc
$2.05+2.50%
OBD.LOxford BioDynamics Plc
$0.20+0.00%
SUN.LSurgical Innovations Group plc
$0.45+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About RUA

What is the current price of Rua Life Sciences Plc?

Rua Life Sciences Plc is trading at GBX 19.80 per share.

What is the 52-week range for Rua Life Sciences Plc?

Over the past 52 weeks, Rua Life Sciences Plc has traded between GBX 10.42 and GBX 20.94.

How much debt does Rua Life Sciences Plc have?

As of the most recent reporting period, Rua Life Sciences Plc reported total debt of $794,000.

How much cash does Rua Life Sciences Plc have on hand?

Rua Life Sciences Plc reported $3.25M in cash and cash equivalents in its most recent financial results.

What is Rua Life Sciences Plc’s dividend yield?

Rua Life Sciences Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.